Wed, December 14, 2022

Justin Bowers Initiated (TXG) at Strong Buy and Held Target at $50 on, Dec 14th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-50-on-dec-14th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Justin Bowers of Deutsche Bank, Initiated "10x Genomics, Inc." (TXG) at Strong Buy and Held Target at $50 on, Dec 14th, 2022.

Justin has made no other calls on TXG in the last 4 months.



There are 2 other peers that have a rating on TXG. Out of the 2 peers that are also analyzing TXG, 0 agree with Justin's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Justin


  • Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $64 on, Friday, November 4th, 2022
  • Matthew Sykes of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $25 on, Thursday, October 13th, 2022